Protheragen Advances Gene Therapy Research with Comprehensive Adeno-Associated Virus (AAV) Vector Platform
Protheragen, a leading biotechnology company specializing in innovative genetic solutions, announced the expansion of its comprehensive Adeno-Associated Virus (AAV) Vector Platform services to meet the growing demands of gene therapy research and development.
Adeno-associated virus (AAV) is a non-enveloped virus that can transport DNA to target cells through genetic engineering, and...
0 Bình luận
0 Chia sẻ
81 Lượt xem
English
العربية
Français
Español
Português
Deutsch
Türkçe
Nederlands
Italiano
Русский
Română
Português
Ελληνικά